Why the study?
The study was conducted to address the role of noninvasive screening tools in diagnosing atrial fibrillation in Argentinian clinical practice.
Do clinical characteristics and management strategies differ in patients with newly diagnosed atrial fibrillation detected by noninvasive screening compared to standard detection?
Do clinical characteristics and management strategies differ in patients with newly diagnosed atrial fibrillation detected by noninvasive screening compared to standard detection?
In Argentinian clinical practice, noninvasive screening tools primarily detect atrial fibrillation in asymptomatic, high-risk patients who are subsequently managed with less vitamin K antagonist use and more electrical cardioversion compared to those detected by standard methods.
Answers are grounded in this paper and cite their sources.
Screening-detected AF associations should not yet change practice; leaves open whether detection method alters outcomes or anticoagulation decisions.
Background Patient characteristics and outcomes of newly diagnosed atrial fibrillation (AF) have been investigated in large registries. Objective To address the role of noninvasive screening tools in diagnosing AF in the Argentinian clinical practice. Methods Observational retrospective study. Patients clinical characteristics and management of newly diagnosed AF detected by a noninvasive screening tool were analyzed. Results Of 12,635 AF outpatients, 1,018/5,947 (17.1%) of newly diagnosed AF were detected by a screening method: ECG monitoring device (82.3%), self-pulse palpation (17.3%), and smartwatch/smartphone (0.4%). Screening (+) patients were older (73 [63-81] vs. 72 [65-81], P=NS) and had a higher prevalence of ≥75 years old patients (45.5% vs. 37.9%, P<0.001) and females (42.5% vs. 41.2%, P=NS). Adjusted results (OR 95%CI) by multivariate analysis showed that alcohol consumption (1.74 [1.14-2.65]), thyroid dysfunction (1.26 [1.07-1.49]), coronary artery disease (CAD) (1.40 [1.19-1.64]), paroxysmal AF (2.39 [1.94-2.96]), asymptomatic condition (2.44 [2.07-2.86]), high risk of thromboembolic and bleeding complications (CHA 2 DS 2 -Vasc 1.18 [1.06-1.32] and HASBLED 1.25 [1.08-1.46]), and heart failure (1.23 [1.01-1.49]) were associated with screening (+) patients. Although no difference in oral anticoagulation therapy (OAC) was detected, vitamin K antagonists (VKAs) were less frequently prescribed (0.66 [0.53-0.82]). Electrical cardioversion was preferred over class I and III antiarrhythmic drugs (AADs) (1.33 [1.07-1.66] vs. 0.61 [0.44-0.84] and 0.79 [0.64-0.97]). Conclusions Noninvasive screening tools are mainly used in Argentinian clinical practice to detect AF in asymptomatic patients at high risk of thromboembolic and bleeding complications. VKAs are less prescribed, and electrical cardioversion is preferred over AADs for initial rhythm control.
No takes yet. Share an insight, caveat, or question.
Aguinaga et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: